Exact Mass: 433.98691399999996

Exact Mass Matches: 433.98691399999996

Found 37 metabolites which its exact mass value is equals to given mass value 433.98691399999996, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Resmetirom

Resmetirom

C17H12Cl2N6O4 (434.0297052)


C78276 - Agent Affecting Digestive System or Metabolism

   
   
   
   
   

(7E,9R,10R,13E,15Z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid|xestospongienol C

(7E,9R,10R,13E,15Z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid|xestospongienol C

C16H20Br2O4 (433.972824)


   
   

4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfobenzoyl)-2-methoxybenzenesulfonic acid

4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfobenzoyl)-2-methoxybenzenesulfonic acid

C15H14O11S2 (433.9977534)


   

cyclopenta-1,4-dien-1-yl(trimethyl)silane,zirconium(4+),dichloride

cyclopenta-1,4-dien-1-yl(trimethyl)silane,zirconium(4+),dichloride

C16H26Cl2Si2Zr (433.9997096000001)


   

N-[2-[2-(benzothiazol-2-ylsulfanylamino)ethoxy]ethyl]benzothiazole-2-s ulfenamide

N-[2-[2-(benzothiazol-2-ylsulfanylamino)ethoxy]ethyl]benzothiazole-2-s ulfenamide

C18H18N4OS4 (434.0363418)


   

1,5-i-aedans

1,5-i-aedans

C14H15IN2O4S (433.979726)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

4-CHLORO-3-[[[[[5-(3-CHLOROPHENYL)-2-FURANYL]CARBONYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID

4-CHLORO-3-[[[[[5-(3-CHLOROPHENYL)-2-FURANYL]CARBONYL]AMINO]THIOXOMETHYL]AMINO]-BENZOIC ACID

C19H12Cl2N2O4S (433.98948120000006)


   

(Bromomethyl)(triphenyl)phosphonium bromide

(Bromomethyl)(triphenyl)phosphonium bromide

C19H17Br2P (433.9434532)


   

Lanifibranor

Lanifibranor

C19H15ClN2O4S2 (434.01617400000003)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Lanifibranor is a pan peroxisome proliferator-activated receptor (PPAR) agonist with EC50s of 1.5, 0.87 and 0.21 μM for human PPARα, PPARσ and PPARγ, respectively.

   
   

dipotassium,5-[2-(1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonan-5-yloxy)ethoxy]-1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonane

dipotassium,5-[2-(1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonan-5-yloxy)ethoxy]-1,4,6,9-tetraoxa-5-silanuidaspiro[4.4]nonane

C10H20K2O10Si2 (433.98691399999996)


   

bis(3-acetyl-6-methyl-2h-pyran-2,4(3h)-dionato) zinc dihydrate

bis(3-acetyl-6-methyl-2h-pyran-2,4(3h)-dionato) zinc dihydrate

C16H18O10Zn (434.0191378)


   

5-Iodo-2-deoxyuridine-5-monophosphate

5-Iodo-2-deoxyuridine-5-monophosphate

C9H12IN2O8P (433.9376032)


   

5-(4-bromophenyl)-N-[[(2-propyl-5-tetrazolyl)amino]-sulfanylidenemethyl]-2-furancarboxamide

5-(4-bromophenyl)-N-[[(2-propyl-5-tetrazolyl)amino]-sulfanylidenemethyl]-2-furancarboxamide

C16H15BrN6O2S (434.016051)


   

N-(5-bromo-6-methyl-2-pyridinyl)-3-(2-oxo-1-benzopyran-3-yl)benzamide

N-(5-bromo-6-methyl-2-pyridinyl)-3-(2-oxo-1-benzopyran-3-yl)benzamide

C22H15BrN2O3 (434.02659800000004)


   

N-(4-bromophenyl)-4-[(2E)-2-(2-hydroxy-5-nitrobenzylidene)hydrazino]-4-oxobutanamide

N-(4-bromophenyl)-4-[(2E)-2-(2-hydroxy-5-nitrobenzylidene)hydrazino]-4-oxobutanamide

C17H15BrN4O5 (434.022576)


   

4-[(2,4-Dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate

4-[(2,4-Dimethylphenyl)diazenyl]-3-hydroxynaphthalene-2,7-disulfonate

C18H14N2O7S2-2 (434.0242414)


   

iron(III) dicitrate(3-)

iron(III) dicitrate(3-)

C12H10FeO14 (433.941995)


The complex formed between iron(III) and citrate.

   

(7e,9s,10s,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9s,10s,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

(9r,10r)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9r,10r)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

(7e,9r,10s,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9r,10s,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

(9s,10r)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9s,10r)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

n-[2-(4-hydroxy-3-iodophenyl)ethyl]-2-(1h-indol-3-yl)-2-oxoacetamide

n-[2-(4-hydroxy-3-iodophenyl)ethyl]-2-(1h-indol-3-yl)-2-oxoacetamide

C18H15IN2O3 (434.012739)


   

4,5-dibromo-n-[3-(2-hydroxy-1-methyl-5-oxo-4h-imidazol-4-yl)propyl]-1-methylpyrrole-2-carboxamide

4,5-dibromo-n-[3-(2-hydroxy-1-methyl-5-oxo-4h-imidazol-4-yl)propyl]-1-methylpyrrole-2-carboxamide

C13H16Br2N4O3 (433.9589066)


   

(9r,10s)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9r,10s)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

4,5-dibromo-n-{3-[(4r)-2-hydroxy-1-methyl-5-oxo-4h-imidazol-4-yl]propyl}-1-methylpyrrole-2-carboxamide

4,5-dibromo-n-{3-[(4r)-2-hydroxy-1-methyl-5-oxo-4h-imidazol-4-yl]propyl}-1-methylpyrrole-2-carboxamide

C13H16Br2N4O3 (433.9589066)


   

(9s,10s)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9s,10s)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

(7e,9s,10r,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9s,10r,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

(7e,9r,10r,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9r,10r,13e,15z)-14,16-dibromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H20Br2O4 (433.972824)


   

methyl 3-chloro-6-(3,5-dichloro-2-hydroxy-4-methoxy-6-methylphenoxy)-4-methoxy-2-methylbenzoate

methyl 3-chloro-6-(3,5-dichloro-2-hydroxy-4-methoxy-6-methylphenoxy)-4-methoxy-2-methylbenzoate

C18H17Cl3O6 (434.00906720000006)